Mark T. Lin

20 papers receiving 1.5k citations

Mark T. Lin's Hit Papers

Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation 2023 · 247 citations
2470+1+2Years since publication50100150200

Peers

Mark T. Lin
Comparison fields: 5 of 75
  • Immunology 345
  • Critical Care and Intensive Care Medicine 74
  • Oncology 289
  • Neurology 86
  • Animal Science and Zoology 102
Replace Gloria Vachino with:
Gloria Vachino United States
Kathleen Wardwell United States
Olivier Spertini Switzerland
Beatty Pg United States
Bas Heinhuis Netherlands
Cécile Braudeau France
Boris Eugen Schleiffenbaum Switzerland
John Cardone United Kingdom
Jinlin Miao China
Michael Uhlin Sweden
Mark T. Lin relative to Gloria Vachino United States Gloria Vachino's profile →
Citations per field
00.5×10×20×30×40×
Gloria Vachino · 1×
Citations per year

Countries citing papers authored by Mark T. Lin

Since Specialization
Citations

This map shows the geographic impact of Mark T. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Lin more than expected).

Fields of papers citing papers by Mark T. Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Lin. The network helps show where Mark T. Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark T. Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark T. Lin Line = papers co-authored together Mark T. Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation
Hit paper breakdown →
2023247
2 1999191
3 2004175
4 1998140
5 2007104
6 2023102
7 202293
8 199988
9 200978
10 199770
11 200056
12 199852
13 200152
14 201948
15 201522
16 202520
17 202016
18 199810
19 19985
20
Immune regulation of coronavirus-induced demyelinating encephalomyelitis.
19971

About Mark T. Lin

Mark T. Lin is a scholar working on Immunology, Pathology and Forensic Medicine, Virology, Biotechnology and Animal Science and Zoology, having authored 20 papers that have together received 1.6k indexed citations. Recurring topics across this work include interferon and immune responses (5 papers), Multiple Sclerosis Research Studies (4 papers), T-cell and B-cell Immunology (3 papers), Lung Cancer Treatments and Mutations (2 papers), Infectious Encephalopathies and Encephalitis (2 papers), HIV Research and Treatment (2 papers), Hepatitis B Virus Studies (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Immunology (345 citations), Critical Care and Intensive Care Medicine (74 citations), Oncology (289 citations), Neurology (86 citations) and Animal Science and Zoology (102 citations). Mark T. Lin has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include David R. Hinton, Stephen A. Stohlman, Timothy E. Albertson, Cornelia C. Bergmann, Beatriz Parra, Norman W. Marten, José María Mato, Shelly Chi-Loo Lu, Dennis John Kuo and Roel C. van der Veen. Their work appears in journals such as The Journal of Immunology, Nature Medicine, Virology, Advances in experimental medicine and biology and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact